CARLI TURNGREN: Open Payments
NPI 1154056943 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $573 · 2025 $476
Food & beverage: $266Education: $209
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $258 |
| ABBVIE INC. | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: VRAYLAR, AUSTEDO XR, REXULTI, ARISTADA, Auvelity, INGREZZA.
Industry payments across PA — which companies pay providers there.
